Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-30
2011-08-30
Shaw, Amanda (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S024310, C435S287200
Reexamination Certificate
active
08008003
ABSTRACT:
The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5202429 (1993-04-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: 5474796 (1995-12-01), Brennan
patent: RE35491 (1997-04-01), Cline et al.
patent: 5670325 (1997-09-01), Lapidus et al.
patent: 5741650 (1998-04-01), Lapidus et al.
patent: 5830665 (1998-11-01), Shuber et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5861278 (1999-01-01), Wong et al.
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5962312 (1999-10-01), Plowman et al.
patent: 5985553 (1999-11-01), King et al.
patent: 6020137 (2000-02-01), Lapidus et al.
patent: 6100029 (2000-08-01), Lapidus et al.
patent: 6143529 (2000-11-01), Lapidus et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6171798 (2001-01-01), Levine et al.
patent: 6203993 (2001-03-01), Shuber et al.
patent: 6207401 (2001-03-01), Plowman et al.
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6214558 (2001-04-01), Shuber et al.
patent: 6245523 (2001-06-01), Altieri
patent: 6248535 (2001-06-01), Danenberg et al.
patent: 6251601 (2001-06-01), Bao et al.
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6322986 (2001-11-01), Ross
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 6620606 (2003-09-01), Bandman et al.
patent: 6696558 (2004-02-01), Reed et al.
patent: 6716575 (2004-04-01), Plowman et al.
patent: 6750013 (2004-06-01), Gish et al.
patent: 6800737 (2004-10-01), Altieri
patent: 6943150 (2005-09-01), Altieri
patent: 2002/0004491 (2002-01-01), Xu et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2002/0039764 (2002-04-01), Rosen
patent: 2002/0160395 (2002-10-01), Altieri et al.
patent: 2002/0194022 (2002-12-01), Comite
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0198972 (2003-10-01), Erlander et al.
patent: 2003/0219771 (2003-11-01), Bevilacqua et al.
patent: 2003/0229455 (2003-12-01), Bevilacqua et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0126775 (2004-07-01), Altieri et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2009/0298701 (2009-12-01), Baker et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO012227 (2001-02-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/44413 (2002-06-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO0244413 (2002-06-01), None
patent: WO 02/017852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO 03/078662 (2003-09-01), None
patent: WO 03/083096 (2003-10-01), None
patent: WO 2004/000094 (2003-12-01), None
Giaccone et al. EGFR inhibitors: what have we learned from the treatment of lung cancer. Nov. 2005 Nature vol. 2, No. 11 pp. 554-561.
Filmus, Jorge. Glypicans in growth control and cancer. 2001. Glycobiology. vol. 11, No. 3, pp. 19R-23R.
Hlubek, Falk et al. Expression of the Invasion Factor LAminin gamma2 in colorectal carcinomas is regulated by beta catenin. Nov. 2001. Cancer Research vol. 61, pp. 8089-8093.
Wu, Thomas. Analysing gene expression data from DNA microarrys to identify candidate genes. 2001. Journal of Pathology. vol. 195 pp. 53-65.
Lucentini, Jack. Gene Association Studies Typically Wrong. 2004. The Scientist. vol. 18 pp. 1-4.
Evans, William et al. Moving towards individualized medicine with pharmacogenomics. 2004. Nature vol. 429, pp. 464-468.
Newton, MA et al. On differentail variablility of expression ratios: improving statistical inference about gene expression changes from microarray data. Journal of Computational Biology 2001. vol. 8, No. 1 pp. 37-52.
Cheung, Vivian et al. Natural variation in human gene expression assessed in lymphoblastoid cells. 2003 Nature Genetics vol. 33 pp. 422-425.
Lee, Wooin et al. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. The Oncologist 2005. vol. 10 pp. 104-111.
Riese, David et al. Specificity within the EFG family/ErbB receptor family signaling network: BioEssays 1998. vol. 20 pp. 41-48.
Chun, So Young. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes. 2000. Journal of Korean Medical Science. vol. 15 pp. 696-700.
Salomon, Davide et al. Epidermal growth factor related peptides and their receptors in human malignancies. 1995 Critical Reviews in Oncology/Hematology vol. 19 pp. 183-232.
Notterman, Daniel et al. Transcriptional Gene Expression Profiles of Colorectal Adenoma, Adenocarcinoma, and Normal Tissue Examined by Oligonucleotide Arrays. 2001. Cancer Research vol. 61 pp. 3124-3130.
Lehmann, Ulrich et al. Real Time PCR Analysis of DNA and RNA Extracted from Formalin Fixed and Paraffin Embedded Biopsies. 2001 Methods. vol. 25 pp. 409-418.
Affymetrix array finder at www.affymetrix.com accessed online Jul. 16, 2008.
Airenne, Tomi et al. Differential expression of mouse laminin gamma2 and gamma2* chain transcripts. 2000. Cell Tissue Research. vol. 300 pp. 129-137.
Solmi, Rossella et al. Displayed correlation between gene expression profiled and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 2008 BMC Cancer vol. 8 p. 227.
Thisted, Ronald. What is a p value?. 1998 The University of Chicago. http://www.stat.uchicago.edu/˜thisted.
Bhattacharjae, Arindam, et al., Proc. Natl. Acad. Sci. USA, vol. 98, No. 24, 2001, pp. 13790-13795.
Golub, T.R., et al., Science, vol. 286, 1999, pp. 531-537.
Martin, Katherine J., et al., Cancer Research. 60, 2000, pp. 2232-2238.
Ramaswamy, Sridhar, et. al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 15149-15154.
Rimm, D.L., et al., Molecular Cloning Reveals Alternative Splice Forms of Human a(E) Catenin, Biochemical and Biophysical Research Communications, 1994, vol. 203, pp. 1691-1699.
Sorlie, Therese, et al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, No. 19, pp. 10869-10874.
West, Mike, et al., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, No. 20, pp. 11462-11467.
Yan, Pearlly S., et al., Cancer Research, 2001, vol. 61, pp. 8375-8380.
Yeung, Chen-Hsiang, et al., Bioinformatics, vol. 17, Suppl. 1, 2001, pp. S316-S322.
Zhao, Renbin, et al., Analysis of p53-Regulated Gene Expression Patterns Using Oligonucleotide Arrays, Genes & Development, 2000, vol. 14, pp. 981-993.
Arteaga, C.L, Journal of Clinical Oncology, vol. 19:(18), Suppl. (2001).
Bishop, P.C. et al., Oncogene, 21: 119-127 (2002).
Busse, D. et al., The Journal of Biological Chemistry, 275:(10) 6987-6995 (2000).
Specht, K. et al., American Journal of Phathology, 158:2 (2001).
Brabender, Jan, et al.;Epidermal Grow
Baker Joffre B.
Baselga Jose
Cronin Maureen T.
Shak Steve
Borden Paula A.
Bozicevic Field & Francis LLP.
Genomic Health, Inc.
Shaw Amanda
LandOfFree
Gene expression profiling of EGFR positive cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression profiling of EGFR positive cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling of EGFR positive cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2668932